Literature DB >> 17825923

Mimotope vaccines: epitope mimics induce anti-cancer antibodies.

Angelika B Riemer1, Erika Jensen-Jarolim.   

Abstract

Mimotopes are epitope-mimicking structures. When applied for immunizations they induce desired antibody specificities exclusively based on the principle of molecular mimicry. This is important as antibodies directed against tumor-associated antigens may harbor diverse biological effects depending on their epitope specificity. Thus they may inhibit or promote tumor growth. This review gives an update on different vaccination strategies based on the mimotope concept.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17825923      PMCID: PMC2999752          DOI: 10.1016/j.imlet.2007.07.008

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  49 in total

Review 1.  Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

Authors:  F M Marincola; E M Jaffee; D J Hicklin; S Ferrone
Journal:  Adv Immunol       Date:  2000       Impact factor: 3.543

2.  Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides.

Authors:  A Luzzago; F Felici; A Tramontano; A Pessi; R Cortese
Journal:  Gene       Date:  1993-06-15       Impact factor: 3.688

3.  PSMA mimotope isolated from phage displayed peptide library can induce PSMA specific immune response.

Authors:  Z Y Zhu; C P Zhong; W F Xu; G M Lin; G Q Ye; Y Y Ji; B Sun; M Yeh
Journal:  Cell Res       Date:  1999-12       Impact factor: 25.617

4.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

5.  Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE.

Authors:  E Ganglberger; K Grunberger; B Sponer; C Radauer; H Breiteneder; G Boltz-Nitulescu; O Scheiner; E Jensen-Jarolim
Journal:  FASEB J       Date:  2000-11       Impact factor: 5.191

6.  Identification of epitope regions recognized by tumor inhibitory and stimulatory anti-ErbB-2 monoclonal antibodies: implications for vaccine design.

Authors:  Y L Yip; G Smith; J Koch; S Dübel; R L Ward
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

7.  Tumor-inhibitory antibodies to HER-2/ErbB-2 may act by recruiting c-Cbl and enhancing ubiquitination of HER-2.

Authors:  L N Klapper; H Waterman; M Sela; Y Yarden
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

8.  Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.

Authors:  A Mittelman; Z J Chen; C C Liu; S Hirai; S Ferrone
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

9.  Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.

Authors:  A Meola; P Delmastro; P Monaci; A Luzzago; A Nicosia; F Felici; R Cortese; G Galfrè
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

10.  Generation of Peptide mimics of the epitope recognized by trastuzumab on the oncogenic protein Her-2/neu.

Authors:  Angelika B Riemer; Markus Klinger; Stefan Wagner; Astrid Bernhaus; Luca Mazzucchelli; Hubert Pehamberger; Otto Scheiner; Christoph C Zielinski; Erika Jensen-Jarolim
Journal:  J Immunol       Date:  2004-07-01       Impact factor: 5.422

View more
  15 in total

Review 1.  Affinity selection of epitope-based vaccines using a bacteriophage virus-like particle platform.

Authors:  John P O'Rourke; David S Peabody; Bryce Chackerian
Journal:  Curr Opin Virol       Date:  2015-03-29       Impact factor: 7.090

Review 2.  Phage display in molecular imaging and diagnosis of cancer.

Authors:  Susan L Deutscher
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

3.  Peptide epitope identification by affinity selection on bacteriophage MS2 virus-like particles.

Authors:  Bryce Chackerian; Jerri do Carmo Caldeira; Julianne Peabody; David S Peabody
Journal:  J Mol Biol       Date:  2011-04-09       Impact factor: 5.469

4.  Immunization with the SDPM1 peptide lowers amyloid plaque burden and improves cognitive function in the APPswePSEN1(A246E) transgenic mouse model of Alzheimer's disease.

Authors:  Chiou-Miin Wang; Sarah Devries; Marybeth Camboni; Matthew Glass; Paul T Martin
Journal:  Neurobiol Dis       Date:  2010-05-20       Impact factor: 5.996

5.  Automated detection of conformational epitopes using phage display Peptide sequences.

Authors:  Surendra S Negi; Werner Braun
Journal:  Bioinform Biol Insights       Date:  2009-07-01

6.  SAROTUP: scanner and reporter of target-unrelated peptides.

Authors:  Jian Huang; Beibei Ru; Shiyong Li; Hao Lin; Feng-Biao Guo
Journal:  J Biomed Biotechnol       Date:  2010-03-21

Review 7.  The roles of mast cells in anticancer immunity.

Authors:  Dyana K Dalton; Randolph J Noelle
Journal:  Cancer Immunol Immunother       Date:  2012-04-18       Impact factor: 6.968

8.  MimoDB 2.0: a mimotope database and beyond.

Authors:  Jian Huang; Beibei Ru; Ping Zhu; Fulei Nie; Jun Yang; Xuyang Wang; Ping Dai; Hao Lin; Feng-Biao Guo; Nini Rao
Journal:  Nucleic Acids Res       Date:  2011-11-03       Impact factor: 16.971

9.  Mimotope vaccination for epitope-specific induction of anti-VEGF antibodies.

Authors:  Weina Li; Yonggang Ran; Meng Li; Kuo Zhang; Xin Qin; Xiaochang Xue; Cun Zhang; Qiang Hao; Wei Zhang; Yingqi Zhang
Journal:  BMC Biotechnol       Date:  2013-09-27       Impact factor: 2.563

10.  Characterisation of an engineered trastuzumab IgE antibody and effector cell mechanisms targeting HER2/neu-positive tumour cells.

Authors:  Panagiotis Karagiannis; Josef Singer; James Hunt; Samuel K E Gan; Sarah M Rudman; Diana Mechtcheriakova; Regina Knittelfelder; Tracy R Daniels; Philip S Hobson; Andrew J Beavil; James Spicer; Frank O Nestle; Manuel L Penichet; Hannah J Gould; Erika Jensen-Jarolim; Sophia N Karagiannis
Journal:  Cancer Immunol Immunother       Date:  2008-10-22       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.